Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampyra for Upper Extremity Function in Multiple Sclerosis
NCT02259361Phase 4Unknown
- Sponsor
- Sheba Medical Center
- Start
- Nov 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dalfampridine in multiple sclerosis (MS), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02259361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259361.